Paris, France

Bioproject

Calculating rank
USPTO Granted Patents = 4

% Expired Patents = 50.0

Forward Citations = 16

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Jean-Charles Schwartz (4 out of 62 patents)

silverMedal Jeanne-Marie Lecomte (3 out of 56 patents)

bronzeMedal Marc Capet (2 out of 41 patents)

4.  Denis Danvy (2 out of 21 patents)

5.  Isabelle Berrebi-Bertrand (1 out of 11 patents)

6.  Stéphane Krief (1 out of 7 patents)

7.  Olivier Labeeuw (1 out of 8 patents)

8.  Philippe Robert (1 out of 13 patents)

9.  Thierry Calmels (1 out of 8 patents)

10.  Xavier Billot (1 out of 6 patents)

11.  Xavier Ligneau (1 out of 20 patents)

12.  Nicolas Levoin (1 out of 11 patents)

13.  Walter Schunack (1 out of 17 patents)

14.  Jean-Michel Arrang (1 out of 13 patents)

15.  Monique Garbarg (1 out of 12 patents)


4 patents:

Company Overview
Bioproject is a leading biotechnology company that specializes in developing innovative solutions and products for the healthcare industry. With a focus on research and development, Bioproject is committed to advancing medical technology and improving patient outcomes. Their team of experts work tirelessly to create cutting-edge biotherapeutics and diagnostics that address a wide range of medical conditions. Visit their website to learn more about their groundbreaking work.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#640 in Paris

#3,356 in France

Paris, FR
Paris, France
Forward Citations = 16

18 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioproject. Retrieved from https://idiyas.com/company/bioproject

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…